Literature DB >> 29903906

Parkin negatively regulates the antiviral signaling pathway by targeting TRAF3 for degradation.

Di Xin1, Haiyan Gu1, Enping Liu1, Qinmiao Sun2.   

Abstract

Chronic neuroinflammation is a characteristic of Parkinson's disease (PD). Previous investigations have shown that Parkin gene mutations are related to the early-onset recessive form of PD and isolated juvenile-onset PD. Further, Parkin plays important roles in mitochondrial quality control and cytokine-induced cell death. However, whether Parkin regulates other cellular events is still largely unknown. In this study, we performed overexpression and knockout experiments and found that Parkin negatively regulates antiviral immune responses against RNA and DNA viruses. Mechanistically, we show that Parkin interacts with tumor necrosis factor receptor-associated factor 3 (TRAF3) to regulate stability of TRAF3 protein by promoting Lys48-linked ubiquitination. Our findings suggest that Parkin plays a novel role in innate immune signaling by targeting TRAF3 for degradation and maintaining the balance of innate antiviral immunity.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Parkin; TRAF3; cell signaling; innate immunity; interferon; ubiquitylation (ubiquitination)

Mesh:

Substances:

Year:  2018        PMID: 29903906      PMCID: PMC6078441          DOI: 10.1074/jbc.RA117.001201

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Parkin-induced mitophagy in the pathogenesis of Parkinson disease.

Authors:  Derek Narendra; Atsushi Tanaka; Der-Fen Suen; Richard J Youle
Journal:  Autophagy       Date:  2009-07-22       Impact factor: 16.016

2.  Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane.

Authors:  Saori R Yoshii; Chieko Kishi; Naotada Ishihara; Noboru Mizushima
Journal:  J Biol Chem       Date:  2011-03-18       Impact factor: 5.157

Review 3.  Complexity and dynamics of host-fungal interactions.

Authors:  Fabien Cottier; Norman Pavelka
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

4.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

Review 5.  The role of innate and adaptive immunity in Parkinson's disease.

Authors:  George T Kannarkat; Jeremy M Boss; Malú G Tansey
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

6.  Syndecan-4 negatively regulates antiviral signalling by mediating RIG-I deubiquitination via CYLD.

Authors:  Wei Lin; Jing Zhang; Haiyan Lin; Zexing Li; Xiaofeng Sun; Di Xin; Meng Yang; Liwei Sun; Lin Li; Hongmei Wang; Dahua Chen; Qinmiao Sun
Journal:  Nat Commun       Date:  2016-06-09       Impact factor: 14.919

7.  Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy.

Authors:  Matthew E Gegg; J Mark Cooper; Kai-Yin Chau; Manuel Rojo; Anthony H V Schapira; Jan-Willem Taanman
Journal:  Hum Mol Genet       Date:  2010-09-24       Impact factor: 6.150

8.  COX5B regulates MAVS-mediated antiviral signaling through interaction with ATG5 and repressing ROS production.

Authors:  Yuanyuan Zhao; Xiaofeng Sun; Xuanli Nie; Liwei Sun; Tie-Shan Tang; Dahua Chen; Qinmiao Sun
Journal:  PLoS Pathog       Date:  2012-12-20       Impact factor: 6.823

9.  OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3.

Authors:  Hongbo Hu; George C Brittain; Jae-Hoon Chang; Nahum Puebla-Osorio; Jin Jin; Anna Zal; Yichuan Xiao; Xuhong Cheng; Mikyoung Chang; Yang-Xin Fu; Tomasz Zal; Chengming Zhu; Shao-Cong Sun
Journal:  Nature       Date:  2013-01-20       Impact factor: 69.504

10.  Hepatitis B Virus-Induced Parkin-Dependent Recruitment of Linear Ubiquitin Assembly Complex (LUBAC) to Mitochondria and Attenuation of Innate Immunity.

Authors:  Mohsin Khan; Gulam Hussain Syed; Seong-Jun Kim; Aleem Siddiqui
Journal:  PLoS Pathog       Date:  2016-06-27       Impact factor: 6.823

View more
  7 in total

1.  Macrophage migration inhibitory factor enhances influenza-associated mortality in mice.

Authors:  Candice A Smith; Daniel J Tyrell; Upasana A Kulkarni; Sherri Wood; Lin Leng; Rachel L Zemans; Richard Bucala; Daniel R Goldstein
Journal:  JCI Insight       Date:  2019-07-11

2.  Mitochondrial Protein PINK1 Positively Regulates RLR Signaling.

Authors:  Jun Zhou; Rui Yang; Zhaoru Zhang; Qianru Liu; Yuanyuan Zhang; Qingqing Wang; Hongbin Yuan
Journal:  Front Immunol       Date:  2019-05-14       Impact factor: 7.561

Review 3.  The Evolving Role of TRAFs in Mediating Inflammatory Responses.

Authors:  Bipandeep Dhillon; Fatemah Aleithan; Zahi Abdul-Sater; Ali A Abdul-Sater
Journal:  Front Immunol       Date:  2019-02-04       Impact factor: 7.561

4.  Mice deficient in NKLAM have attenuated inflammatory cytokine production in a Sendai virus pneumonia model.

Authors:  Donald W Lawrence; Laurie P Shornick; Jacki Kornbluth
Journal:  PLoS One       Date:  2019-09-20       Impact factor: 3.240

Review 5.  The Functional Deubiquitinating Enzymes in Control of Innate Antiviral Immunity.

Authors:  Zhi Zong; Zhengkui Zhang; Liming Wu; Long Zhang; Fangfang Zhou
Journal:  Adv Sci (Weinh)       Date:  2020-12-15       Impact factor: 16.806

Review 6.  Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing.

Authors:  Kiramage Chathuranga; Asela Weerawardhana; Niranjan Dodantenna; Jong-Soo Lee
Journal:  Exp Mol Med       Date:  2021-11-16       Impact factor: 8.718

7.  Transcriptome Analysis of Retinoic Acid-Inducible Gene I Overexpression Reveals the Potential Genes for Autophagy-Related Negative Regulation.

Authors:  Shaotang Ye; Chen Tan; Xiaoyun Yang; Ji Wang; Qi Li; Liang Xu; Zhen Wang; Jianwei Mao; Jingyu Wang; Kui Cheng; Aolei Chen; Pei Zhou; Shoujun Li
Journal:  Cells       Date:  2022-06-23       Impact factor: 7.666

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.